Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tormod K Guren

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 24, 2003
Role of ERK, p38 and PI3-kinase in EGF receptor-mediated mitogenic signalling in cultured rat hepatocytes: requirement for sustained ERK activationG Hege Thoresen, Tormod K Guren, Thoralf Christoffersen
Acta Oncologica (Stockholm, Sweden)|June 19, 2018
Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipientsTor Magnus Smedman, Pål-Dag Line, Tormod K Guren, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 2, 2019
Combination therapies with HSP90 inhibitors against colorectal cancerKushtrim Kryeziu, Jarle Bruun, Tormod K Guren, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 22, 2022
Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatarsKushtrim Kryeziu, Christian H Bergsland, Tormod K Guren, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 22, 2005
[Antineoplastic agents targeting tyrosine kinases]Tormod K Guren, Thoralf Christoffersen, G Hege Thoresen, et al.
European Journal of Pharmacology|October 20, 2009
Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issuesThoralf Christoffersen, Tormod K Guren, Karen-Lise Garm Spindler, et al.
Journal of Cellular Physiology|May 27, 2003
EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytesTormod K Guren, John Ødegård, Hilde Abrahamsen, et al.
Annals of Surgery|June 21, 2014
Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?Svein Dueland, Tormod K Guren, Morten Hagness, et al.
British Journal of Cancer|April 20, 2022
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysisLouise B Callesen, Julian Hamfjord, Anders K Boysen, et al.
NPJ Precision Oncology|February 27, 2026
Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trialAnita Sveen, Christian H Bergsland, Barbara Niederdorfer, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 24, 2003
Role of ERK, p38 and PI3-kinase in EGF receptor-mediated mitogenic signalling in cultured rat hepatocytes: requirement for sustained ERK activationG Hege Thoresen, Tormod K Guren, Thoralf Christoffersen
Acta Oncologica (Stockholm, Sweden)|June 19, 2018
Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipientsTor Magnus Smedman, Pål-Dag Line, Tormod K Guren, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 2, 2019
Combination therapies with HSP90 inhibitors against colorectal cancerKushtrim Kryeziu, Jarle Bruun, Tormod K Guren, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 22, 2022
Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatarsKushtrim Kryeziu, Christian H Bergsland, Tormod K Guren, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 22, 2005
[Antineoplastic agents targeting tyrosine kinases]Tormod K Guren, Thoralf Christoffersen, G Hege Thoresen, et al.
European Journal of Pharmacology|October 20, 2009
Cancer therapy targeted at cellular signal transduction mechanisms: strategies, clinical results, and unresolved issuesThoralf Christoffersen, Tormod K Guren, Karen-Lise Garm Spindler, et al.
Journal of Cellular Physiology|May 27, 2003
EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytesTormod K Guren, John Ødegård, Hilde Abrahamsen, et al.
Annals of Surgery|June 21, 2014
Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?Svein Dueland, Tormod K Guren, Morten Hagness, et al.
British Journal of Cancer|April 20, 2022
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysisLouise B Callesen, Julian Hamfjord, Anders K Boysen, et al.
NPJ Precision Oncology|February 27, 2026
Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trialAnita Sveen, Christian H Bergsland, Barbara Niederdorfer, et al.
Pageof 3